Last month, the U.S. Preventive Services Task Force recommended physicians stop ordering routine tests to detect prostate cancer in men.
The risks, says the study group, outweigh the benefits.
Howls of protest followed from various physicians groups, including an adamant dismissal of the recommendation by Irvine, Calif.-based radiation oncologist Dr. Kenneth M. Tokita.
Tokita insists all men should have an initial prostate-specific antigen test at age 40 to determine their risk level for cancer.
Q: Why are you advocating this testing?